Anthem Biosciences Share Price Target 2026 to 2050

Anthem Biosciences Ltd (NSE: ANTHEM) is a top biotech company in India that helps make important products like medicines, vitamins, and health supplements. It works with global pharmaceutical and life sciences companies to develop and manufacture high-quality drugs, enzymes, and other biotech solutions. Its services include custom pharmaceutical manufacturing, contract research, and biotech product development, making it a trusted partner in the pharmaceutical and biotechnology industry.

Anthem Biosciences Fundamental Analysis

Market Cap.	₹42,534 Cr.
ROE	23%
ROCE	30.7%
P/E	84.0
P/B	17.62
Dividend Yield	0%
Book Value	₹42.92
Face Value	₹2
52-Week High	₹770
52-Week Low	₹701.90

Anthem Biosciences Share Price Target 2026

Anthem Biosciences share price target for 2026 is expected to range from ₹700 to ₹900. Here are three key factors that could affect the company’s share price in 2026:

• Contract Research and Manufacturing Growth: Anthem Biosciences works as a helper partner for big medical and drug companies. When global pharmaceutical firms give more contracts to test and make new medicines, the company earns higher revenues, making investors happy and raising share values.
• Integrated Chemical and Biologic Labs: Anthem has special high-tech laboratories to handle both chemical drugs and complex biological medicines under one roof. Having these rare, advanced facilities attracts large international clients who want quick results, boosting overall business sales and stock appeal.
• Strong Global Client Partnerships: Providing research and manufacturing services to customers in over 44 countries diversifies income sources. Building long-term relationships with foreign biotechnology firms creates steady, repeating yearly orders, which guarantees stable corporate earnings and supports positive stock performance.

Anthem Biosciences Share Price Target 2027

Anthem Biosciences share price target for 2027 is expected to range from ₹900 to ₹1100. Here are three key factors that could affect the company’s share price in 2027:

• Healthy Profit Margins and Returns: Efficiently managing factory costs helps the company maintain high return on equity and strong profit margins. When a business consistently turns a large percentage of its sales into actual net cash profit, stock market investors are willing to pay higher prices.
• Low Debt Financial Stability: Keeping very low levels of bank loans means the company does not waste money paying heavy interest charges. A clean, debt-free balance sheet makes the business safe against economic shocks, encouraging long-term investors to buy and hold the shares safely.
• New Specialty Ingredient Products: Creating unique specialty chemicals, food supplements, and active pharmaceutical ingredients expands market reach. Selling high-margin specialized products instead of basic generic items drives up total profitability, which directly leads to higher stock valuations over time.

Anthem Biosciences Share Price Target 2030

Anthem Biosciences share price target for 2030 is expected to range from ₹2400 to ₹3000. Here are three key factors that could affect the company’s share price in 2030:

• Advanced Automation Technology: Utilizing fully automated laboratory equipment and computerized manufacturing lines lowers human error and speeds up production. Fast, error-free manufacturing saves operational costs, increases delivery output, and builds strong trust with strict global healthcare regulators.
• Booming Global Healthcare Demand: The worldwide demand for new medicines, vaccines, and advanced disease treatments continues to grow rapidly every year. As global spending on healthcare rises, contract research companies like Anthem benefit from a continuous wave of new medical projects.
• High Insider Promoter Confidence: Company founders and core leaders retain a very high percentage of ownership in the business. When founders hold onto most of their shares, it signals to public investors that the management team strongly believes the company will grow successfully.

Anthem Biosciences Share Price Target 2040

Anthem Biosciences share price target for 2040 is expected to range from ₹5300 to ₹6200. Here are three risks & challenges that could affect the company’s share price in 2040:

• High Dependence on Pharma Clients: The business relies heavily on external biotechnology and pharmaceutical companies outsourcing their research projects. If client drug development budgets shrink during a global economic slowdown, Anthem could experience sudden drops in new project contracts and lower revenue.
• Strict Global Regulatory Inspections: Manufacturing medicines requires passing intense quality checks from strict health authorities like the US FDA. If an inspection finds any compliance failure or plant error, regulators can temporarily halt production lines, instantly damaging company reputation and share prices.
• Loss of Specialized Scientific Talent: Drug research and biological testing depend entirely on the brainpower of expert scientists, chemists, and researchers. If top talent leaves to join competing biotechnology firms, innovation slows down, delaying complex medicine projects and hurting company growth.

Anthem Biosciences Share Price Target 2050

Anthem Biosciences share price target for 2050 is expected to range from ₹10600 to ₹11900. Here are three risks & challenges that could affect the company’s share price in 2050:

• Expensive Research Capital Spending: Building modern biotech laboratories and advanced chemical manufacturing plants requires spending huge sums of money upfront. If newly built facilities do not attract enough paying clients quickly, those expensive investments can drag down overall company profit margins.
• Foreign Currency Exchange Fluctuations: Earning a large portion of revenue in foreign currencies like US Dollars exposes the business to shifting global exchange rates. Unpredictable currency swings can reduce the actual cash value converted back into Indian Rupees, affecting quarterly financial results.
• Expensive Stock Valuation Multiples: The stock often trades at a very high price-to-earnings valuation multiple compared to other market sectors. If future quarterly earnings growth slows down even slightly, investors might panic and sell their shares, causing a sharp correction in the stock price.

Anthem Biosciences Share Price Target 2026 to 2050

Year	Target Price (₹)
2026	700 to 900
2027	900 to 1100
2028	1200 to 1500
2029	1700 to 2100
2030	2400 to 3000
2040	5300 to 6200
2050	10600 to 11900

Also Read: Adani Power Share Price Target

Anthem Biosciences Shareholding Pattern

Retail & Others	20.46%
Promoters	74.69%
Foreign Institutions	1.50%
Mutual Funds	2.21%
Other Domestic Institutions	1.14%

Anthem Biosciences Key Competitors

Cipla, Dr. Reddy’s Laboratories, Divi’s Laboratories, Biocon, Laurus Labs, Piramal Pharma Solutions, Glenmark Life Sciences, Syngene International, Jubilant Biosys, and Strides Pharma Science.